## ARE: Alexandria Real Estate Equities, Inc. - XLRE: Real Estate

### Executive Summary

No thesis match: MRS_20 -0.9% below STRENGTH zone (4.0-10.0%); PEG 844.20 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($45.04)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bearish (Bullish: 0, Bearish: 10)

**1. Alexandria Real Estate Equities outlook revised to negative by S&P**
- Source: Investing.com | 20251222T221751 | Bearish | Relevance: 100%
- S&P Global Ratings has revised its outlook on Alexandria Real Estate Equities Inc. to negative from stable, citing industry headwinds in the life science real estate sector. The company is facing declining occupancy and cash NOI, leading to a dividend cut and plans for increased asset sales to mitigate financial pressures. S&P expects the company's adjusted debt to EBITDA ratio to rise and fixed charge coverage to decline in 2026.

**2. Alexandria Real Estate Equities outlook revised to negative by S&P**
- Source: Investing.com | 20251222T220810 | Bearish | Relevance: 100%
- S&P Global Ratings revised its outlook on Alexandria Real Estate Equities Inc. to negative from stable, citing significant industry headwinds in the life science real estate sector. The company has experienced declining same-property cash NOI and occupancy rates, leading S&P to project further drops and an increase in its adjusted debt to EBITDA ratio. Despite measures like a dividend cut and increased asset sales, the outlook remains negative due to persistent market challenges.

**3. Deadline Alert: Alexandria Real Estate Equities, Inc. (ARE)**
- Source: GlobeNewswire | 20251222T180910 | Bearish | Relevance: 100%
- Glancy Prongay & Murray LLP is urging investors of Alexandria Real Estate Equities, Inc. (ARE) who suffered losses to contact them regarding a securities fraud lawsuit. The lawsuit alleges that the company made false and misleading statements and failed to disclose material adverse facts. Investors have until January 26, 2026, to file a lead plaintiff motion in the class action.

**4. Deadline Alert: Alexandria Real Estate Equities, Inc. (ARE)**
- Source: GlobeNewswire | 20251222T175131 | Bearish | Relevance: 100%
- Glancy Prongay & Murray LLP is reminding investors of the January 26, 2026 deadline to file a lead plaintiff motion in a class action lawsuit against Alexandria Real Estate Equities, Inc. The lawsuit alleges that Alexandria made misleading statements and failed to disclose material adverse facts regarding its business, operations, and prospects, specifically concerning its Long Island City property's value and declining growth. This follows a significant drop in Alexandria’s stock price after the company released third-quarter financial results that missed estimates and announced a substantial real estate impairment charge.

**5. ARE Shareholders Have Opportunity to Lead Alexandria Real Estate Equities, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!**
- Source: ACCESS Newswire | 20251222T170910 | Bearish | Relevance: 100%
- Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against Alexandria Real Estate Equities, Inc. (NYSE:ARE) alleging that the company made materially false and misleading statements regarding its Long Island City property. Investors who purchased Alexandria securities between January 27, 2025, and October 27, 2025, are encouraged to contact the law firm to learn about potentially becoming a lead plaintiff in the case, with a deadline of January 26, 2026. The lawsuit claims that the company's positive statements about the LIC property's leasing value were misleading and lacked a reasonable basis, especially concerning its Megacampus™ strategy.

### Analyst Activity

**Target Signal:** BEARISH (Raises: 0, Lowers: 7)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-16 | Jefferies | $47 | $62 | -24% |
| 2025-12-04 | Citigroup | $52 | $61 | -15% |
| 2025-12-04 | Evercore ISI Gr | $64 | $72 | -11% |
| 2025-12-04 | BMO Capital | $60 | $67 | -10% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-16 | Jefferies | main | Hold |
| 2025-12-04 | Citigroup | main | Neutral |
| 2025-12-04 | Evercore ISI Gr | main | Outperform |
| 2025-12-04 | BMO Capital | main | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 8 ($0.14M) |
| Sells | 16 ($4.23M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 47.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 3 |

**Top Holders:**
- Vanguard Group Inc: 14.9% (-1.1%)
- Blackrock Inc.: 10.0% (-10.7%)
- State Street Corpora: 6.5% (+3.7%)
- Apg Asset Management: 3.9% (0.0%)
- JPMORGAN CHASE & CO: 3.3% (+34.1%)

### Key Risks

1. Insider selling cluster: $4.2M in recent transactions.
2. Valuation risk: PEG 844.2x with declining EPS estimates leaves no margin for error.
3. Long-term trend broken: trading 34.2% below SMA200.
4. Falling knife pattern: rapid decline without stabilization, catch risk elevated.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 844.20 signals overvaluation risk, limited margin of safety. Revenue declining -8% YoY, concerning. Analyst sentiment negative (7 target cuts vs 0 raises). Insider selling cluster ($4.2M in 90 days), potential headwind. Institutional flow bullish (5 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $8.4B |
| Beta | 1.33 |
| 52W Range | $44.10 - $105.14 |
| Short Interest | 4.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 844.20 |
| Forward P/E | N/A |
| Current P/E | N/A |
| YoY Growth | N/A |
| EPS Direction | FALLING |

### Technicals

MRS_20 strengthening from -4.3% to -0.9% (+3.4% in 5 days), confirming momentum buildup. Below STRENGTH zone by 4.9pp (needs >4.0% for momentum thesis). Below SMA200 (0.66x), long-term trend not supportive. MACD histogram positive (0.82), confirming momentum. RSI neutral at 43. OFD pattern: +MLL (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -0.90% (CS: 36) | Neutral |
| RSI_14 | 43.0 | Neutral |
| MACD Histogram | 0.82 | Bullish |
| vs SMA20 | 0.997x | Below |
| vs SMA50 | 0.855x | Below |
| vs SMA200 | 0.658x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $48.60
- **Stop Loss:** $45.04 (7.3% risk)
- **Target:** $52.16 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 168
- **Position Value:** $8,164.80
- **Portfolio %:** 8.16%
- **Risk Dollars:** $600.00
- **Risk Per Trade:** 0.60%
- **Modifiers:** L1 120% | L2 50% | Combined 0.60x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-01-26 (Est: $0.42)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.39 | $0.50 | +28.2% |
| 2025Q2 | $0.63 | $0.48 | -24.0% |
| 2025Q1 | $0.60 | $0.51 | -15.5% |
| 2024Q4 | $0.90 | $0.69 | -23.0% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*